25 million children, under the age of 5, in the Sahel could be protected by SMC each year

October 2013

RBM Progress and Impact Series

July 2014

George Jagoe draws attention to P.vivax malaria and highlights the exciting possibility of a single-dose cure for this debilitating disease

July 2014
A call for global collaboration at the UN
A new life-saving drug is injecting hope into the fight against severe malaria in Nigeria.
CCTV journalist reports live from the conference and speaks with MMV's Dr Xavier Ding

Collaborations set to advance life-saving pre-referral treatment for severe malaria

27 November 2014

An investigational medicine being developed for the treatment and relapse prevention of P. vivax

28 April 2014

A significant milestone reached in partnership with MMV

06 February 2014


RBM seeks input for the second Global Malaria Action Plan

20 November 2014

Coartem® Dispersible was developed by Novartis and MMV to change the way children with malaria are treated

19 November 2014

Recognition of project in collaboration with MMV and DNDi to optimize new compounds for parasitic diseases

13 November 2014

First delivery of this life-saving drug made through MMV-led UNITAID-funded "Improving Severe Malaria Outcomes" project

04 November 2014